CN Patent

CN111212657A — 用于药物治疗的司美鲁肽

Assigned to Novo Nordisk AS · Expires 2020-05-29 · 6y expired

What this patent protects

本发明涉及用于体重管理的司美鲁肽。

USPTO Abstract

本发明涉及用于体重管理的司美鲁肽。

Drugs covered by this patent

Patent Metadata

Patent number
CN111212657A
Jurisdiction
CN
Classification
—
Expires
2020-05-29
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.